Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

145.48
+1.711.19%
Volume:5.36M
Turnover:782.90M
Market Cap:58.08B
PE:-18.17
High:148.93
Open:145.41
Low:142.67
Close:143.77
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.66
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.59
PE(LYR):-20.04

Loading ...

Moderna Outlook FY Capex USD 200-300 Million

THOMSON REUTERS
·
Jul 31

Corrected-Moderna Q2 Revenue USD 145 Million VS. Ibes Estimate USD 103 Million (Corrects Amount)

THOMSON REUTERS
·
Jul 31

Movement Alert|Moderna, Inc. Rises 5.03% in Regular Trading, Multiple Analyst Upgrades and Flu Vaccine Catalyst Ahead of Earnings

Market Focus
·
Jul 31

Stock Track | Moderna Soars 5.01% Intraday on Ebola Vaccine Trial Launch, Earnings Anticipation

Stock Track
·
Jul 31

Polymarket Odds: Will MRNA, XOM, CVX Beat Earnings Tomorrow?

TIPRANKS
·
Jul 31

Moderna Targets Ebola With New mRNA Vaccine Trial: What Investors Should Watch

TIPRANKS
·
Jul 31

US Fusion Energy Company Commonwealth Raises $1 Billion in Equity Funding

Reuters
·
Jul 30

Stock Track | Moderna Soars 5.20% Intraday on Goldman Sachs Target Hike and Flu Vaccine Optimism

Stock Track
·
Jul 27

Movement Alert|Moderna, Inc. Rises 5.15% in Regular Trading, Goldman Sachs Target Price Hike and Flu Vaccine Approval Expectations Fuel Rebound

Market Focus
·
Jul 27

Moderna Inc. Stock Falls 5.2%, Underperforms Peers

Dow Jones
·
Jul 25

Cboe data shows mixed options sentiment in Moderna with shares down 4.65%

TIPRANKS
·
Jul 25

Stock Track | Moderna Plunges 5.15% Intraday as Cautious Analyst Views and Q2 Earnings Jitters Mount

Stock Track
·
Jul 24

Movement Alert|Moderna, Inc. Falls 5.07% in Regular Trading, Cautious Analyst Expectations Weigh Ahead of Q2 Earnings

Market Focus
·
Jul 24

Barclays Reaffirms Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
Jul 24

Moderna (MRNA) Receives a Hold from Bernstein

TIPRANKS
·
Jul 23

Cboe data shows mixed options sentiment in Moderna with shares down 1.48%

TIPRANKS
·
Jul 23

Biotech Experts Want FDA Drug Reviews Based on Science, not Politics

Reuters
·
Jul 22

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Moderna Inc. Stock Slides 3.8%, Underperforms Peers

Dow Jones
·
Jul 21

Moderna Says Curevac Broke Agreement by Suing over COVID Vaccine Patents

Reuters
·
Jul 21